Drawing for ECOTERA

USPTO serial 99285352

ECOTERA

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
HARMON KENNEDY, HEATHER N
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Deadline: November 12th, 2026

Need help with ECOTERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $324*

Plus Government fees of $125

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for use in urology; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for Inflammation, Cardiovascular diseases, Gastrointestinal disorders, Neurodegenerative diseases including dementia and cognitive disorders, Endocrine disorders, Immune system disorders, Metabolic syndrome, Reproductive health including urological disorders, Environmental toxin-related diseases, Microplastic-induced diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of hormonal disorders; Therapeutic pharmaceutical for the treatment of Inflammation, Cardiovascular disease, Gastrointestinal disorders, Neurodegenerative diseases including dementia and cognitive disorders, Endocrine disorders, Immune system disorders Metabolic syndrome Reproductive health including urological disorders Environmental toxin-related diseases Microplastic-induced diseases; Plant extracts, other than essential oils, for medical, veterinary and pharmaceutical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
May 12, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 1, 2026ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Feb 6, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 20, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 20, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 14, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 17, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 3, 2025DOCKASSIGNED TO EXAMINER—
Jul 15, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 15, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 15, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance